Revolutionizing HCV Treatment for Injection Drug Users: Insights from the HERO Study
Because of the new therapeutics that are effective in curing hep c, the WHO has set this worldwide goal for hepatitis c eradication, and I think we can do it.
Curious about innovative approaches to treating Hepatitis C in people who inject drugs? This episode of the 'Addiction Medicine Journal Club' is a must-listen. Drs. Sonya Del Tredici and John Keenan dive into the HERO Study, which examines two different models of HCV treatment: a modified directly observed therapy and a patient navigator model. They break down the study's findings, discussing treatment completion rates, adherence, and potential barriers to care. But that's not all.
The hosts also touch on making naloxone nasal spray available over the counter and the rising number of poisonings from cannabis products. Plus, they share insights from episode 16 about in-jail treatment of opioid use disorder, offering resources from JCOIN and a sneak peek at an upcoming paper from the NIH-HEAL Initiative. Whether you're a healthcare professional or someone affected by addiction, this episode offers practical strategies and valuable information to help you stay informed and make a difference.